Loading clinical trials...
Loading clinical trials...
Health-Illness Transition Experiences Among Patients With Pancreatic Cancer
The purpose of this study is to better understand what types of transitions people with pancreatic cancer face when they receive chemotherapy. Again, this study defines transition as a change in a life situation or a status that causes a change in a person's identity, role, behavior, or personal relationships. Examples of transitions include changes in sleeping habits, anxiety, employment, relationship with a higher power, and treatment goals.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, United States
Start Date
June 5, 2020
Primary Completion Date
June 5, 2026
Completion Date
June 5, 2026
Last Updated
July 24, 2025
55
ACTUAL participants
Measurement of Transitions in Cancer Scale (MOT-CA) Survey
BEHAVIORAL
Distress Thermometer Survey
BEHAVIORAL
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
NCT04550494
NCT05053971
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions